Acquiring Company
GSK plc
Acquired Company
RAPT Therapeutics
Description
On March 3, 2026, GSK completed its acquisition of RAPT Therapeutics for $2.2 billion. This strategic move enhances GSK's pipeline with a late-stage food allergy antibody. Following shortly after, GSK also acquired 35Pharma for $950 million, targeting the growing pulmonary hypertension market. These acquisitions are part of GSK's roadmap to achieve £40 billion in annual revenue by 2031.
Quick answer
GSK plc is acquiring RAPT Therapeutics for $2.2 billion, announced March 8, 2026.
- How much did GSK plc pay for RAPT Therapeutics?
- The reported deal value is $2.2 billion.
- What does GSK plc do?
- GSK plc is a global healthcare company that researches and develops innovative pharmaceutical products, including vaccines.
- Where are GSK plc and RAPT Therapeutics based?
- RAPT Therapeutics is based in South San Francisco, California, United States.
- Who are the decision-makers at GSK plc?
- Fundz holds 4 contacts at GSK plc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Kopran Limited to merge with Kopran Laboratories Limited (February 27, 2026)
- Anlon Healthcare acquires Remember India Health Links (April 16, 2026)
- Garda Therapeutics to acquire Assertio for $125.1M, $125M (April 8, 2026)
- Merck acquires JSR Life Sciences' chromatography business (April 2, 2026)
- CORONA Remedies acquires Wokadine® brand from Dr. Reddy's (March 31, 2026)
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
Who to call at GSK plc, and when
When GSK plc changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day GSK plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GSK plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GSK plc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GSK plc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired RAPT Therapeutics?
RAPT Therapeutics was acquired by GSK plc. The deal was reported on March 8, 2026. GSK plc is a global healthcare company that researches and develops innovative pharmaceutical products, including vaccines. GSK plc is publicly traded (GSK) and operates in Manufacturing.
When did GSK plc acquire RAPT Therapeutics?
GSK plc's acquisition of RAPT Therapeutics was reported on March 8, 2026. On March 3, 2026, GSK completed its acquisition of RAPT Therapeutics for $2.2 billion. This strategic move enhances GSK's pipeline with a late-stage food allergy antibody. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does RAPT Therapeutics do?
Rapt Therapeutics is a pharmaceutical firm developing novel therapies for patients living with inflammatory and immunologic diseases. It is privately held, operating in Biotechnology, and is based in South San Francisco.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.